Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01)

Effects of galantamine on attention and memory in Alzheimer's disease measured by computerized neuropsychological tests: results of the Brazilian Multi-Center Galantamine Study (GAL-BRA-01)

Autor Caramelli, Paulo Google Scholar
Chaves, Marcia LF Google Scholar
Engelhardt, Eliasz Google Scholar
Machado, Joao Carlos B Google Scholar
Schultz, Rodrigo Rizek Autor UNIFESP Google Scholar
Vale, Francisco AC Google Scholar
Charchat-Fichman, Helenice Google Scholar
Brazilian Galantamine Study GRP Google Scholar
Instituição Universidade de São Paulo (USP)
Univ Fed Rio Grande Sul
Universidade Federal do Rio de Janeiro (UFRJ)
AURUS IEPE
Universidade Federal de São Paulo (UNIFESP)
Resumo Objective: To investigate the effects of galantamine on the performance of patients with mild to moderate Alzheimer's disease (AD) in a computerized neuropsychological test battery (CNTB). Method: Thirty-three patients with probable AD were treated with galantamine for three months and evaluated in a prospective, open-label, multi-center study. the CNTB and the ADAS-Cog were administered at baseline and after 12 weeks, the CNTB includes reaction time tests to evaluate attention, implicit and episodic memory for faces and words. Statistical comparisons were performed between the results in week 12 versus baseline. Patients who did not reach the therapeutic doses were excluded from the efficacy analysis. Results: Four patients (12.1%) were excluded from the analysis either because of treatment discontinuation (n=3) or because a therapeutic dose was not reached (n=l). the remaining 29 patients were treated with doses of 24 mg/day (n=22) and 16 mg/day (n=7). After 12 weeks, significant reductions in reaction time were seen in the test of episodic memory for faces (p=0.023) and in the test of two-choice reaction time (p=0.039) of the CNTB. Conclusion: Treatment with galantamine produced improvement in computerized tests of attention and episodic memory after 12 weeks, leading to statistically significant reduction in the reaction times.
Assunto Alzheimer's disease
clinical trial
galantamine
computerized neuropsychological tests
attention
memory
Idioma Inglês
Data 2004-06-01
Publicado em Arquivos de Neuro-psiquiatria. São Paulo, SP: Assoc Arquivos de Neuro- Psiquiatria, v. 62, n. 2B, p. 379-384, 2004.
ISSN 0004-282X (Sherpa/Romeo, fator de impacto)
Editor Assoc Arquivos de Neuro- Psiquiatria
Extensão 379-384
Fonte http://dx.doi.org/10.1590/S0004-282X2004000300001
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000222517600001
SciELO S0004-282X2004000300001 (estatísticas na SciELO)
URI http://repositorio.unifesp.br/handle/11600/27777

Mostrar registro completo




Arquivos deste item

Arquivos Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item aparece na(s) seguinte(s) coleção(s)